Firebrick Pharma (ASX:FRE) share price launches 165% following ...

Motley Fool Australia - 28 Jan 2022
Shares in virus-killing nasal spray developer, Firebrick Pharma Limited (ASX: FRE), opened 500% higher than its IPO offer price on its ASX float.

Firebrick Pharma Ltd (ASX: FRE)

The Motley Fool Australia - 31 Jan 2022

Firebrick Pharma (ASX

Firebrick Pharma (ASX:FRE) share price launches 165% following ...

ASX Health Stocks: Firebrick skyrockets 80pc on Nasodine’s US launch

Firebrick Pharma announces the completion of share purchase plan

ASX Health Stocks: Sigma-Chemist Warehouse merger under ACCC scrutiny

Firebrick Pharma Lists New Securities on ASX

Firebrick Pharma says Nasodine Phase 2 COVID-19 trial results published

Firebrick Pharma Ltd (ASX: FRE)

Firebrick Pharma Director Increases Shareholding

“Market is going to be surprised” as Firebrick Pharma set to launch antiviral nasal spray, Nas ...

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners

Firebrick Pharma says nasal spray achieved endpoint in Covid-19 trial

Q+A: Firebrick Pharma is just weeks away from finding out if it has cracked a cure for the common cold

What's New

Get in touch